Equillium, Inc. Profile Avatar - Palmy Investing

Equillium, Inc.

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clin…

Biotechnology
US, La Jolla [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of EQ's Analysis
CIK: 1746466 CUSIP: 29446K106 ISIN: US29446K1060 LEI: - UEI: -
Secondary Listings
EQ has no secondary listings inside our databases.